MedTrace Logo

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

NCT06003049 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-07-17

No results posted yet for this study

Summary

The aim of this clinical trial to determine the safety and effectiveness of treating the COPD symptoms with subcutaneous BOTOX injections in participants with moderate COPD.

Conditions

Interventions

DRUG

OnabotulinumtoxinA

BOTOX injection series

OTHER

Placebo

Placebo injection series

Sponsors & Collaborators

  • RMW Testing

    lead INDUSTRY

Principal Investigators

  • Victoria Do · Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-04-24
Completion
2024-07-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06003049 on ClinicalTrials.gov